NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 161 filers reported holding NEVRO CORP in Q3 2019. The put-call ratio across all filers is 2.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,761,000 | -36.5% | 473,681 | +4.7% | 0.02% | -27.3% |
Q1 2022 | $32,692,000 | +8.8% | 452,562 | +22.1% | 0.03% | +17.9% |
Q4 2021 | $30,039,000 | -30.9% | 370,523 | -0.8% | 0.03% | -34.9% |
Q3 2021 | $43,458,000 | -36.5% | 373,422 | -9.6% | 0.04% | -34.8% |
Q2 2021 | $68,490,000 | +23.4% | 413,117 | +3.8% | 0.07% | +15.8% |
Q1 2021 | $55,497,000 | -24.1% | 397,828 | -5.8% | 0.06% | -29.6% |
Q4 2020 | $73,079,000 | +20.3% | 422,182 | -3.2% | 0.08% | +3.8% |
Q3 2020 | $60,770,000 | +25.4% | 436,253 | +7.6% | 0.08% | +18.2% |
Q2 2020 | $48,455,000 | -39.9% | 405,589 | -49.7% | 0.07% | -2.9% |
Q1 2020 | $80,638,000 | +73.6% | 806,544 | +104.1% | 0.07% | +21.4% |
Q4 2019 | $46,456,000 | +11067.3% | 395,231 | +8071.0% | 0.06% | +5500.0% |
Q3 2019 | $416,000 | +104.9% | 4,837 | +106.3% | 0.00% | – |
Q1 2018 | $203,000 | +2800.0% | 2,345 | +2245.0% | 0.00% | – |
Q4 2017 | $7,000 | -100.0% | 100 | -100.0% | 0.00% | -100.0% |
Q1 2017 | $26,784,000 | – | 285,850 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |